Aldosterone Breakthrough during Angiotensin Receptor Blocker Use: More Questions than Answers?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aldosterone Breakthrough during Angiotensin Receptor Blocker Use: More Questions than Answers?

Published:2013-08-08 Issue:10 Volume:8 Page:1637-1639
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Navaneethan Sankar D.,Bravo Emmanuel L.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference21 articles.

1. Determinants and Changes Associated with Aldosterone Breakthrough after Angiotensin II Receptor Blockade in Patients with Type 2 Diabetes with Overt Nephropathy

2. Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy

3. Effects of Dietary Sodium and Potassium Intake and Acute Stimulation on Aldosterone Output by Isolated Human Adrenal Cells

4. Role of aldosterone in the remnant kidney model in the rat.

5. The Aggravating Mechanisms of Aldosterone on Kidney Fibrosis: Figure 1.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease;International Journal of Molecular Sciences;2024-01-10

2. The Effect of Aldosterone on Cardiorenal and Metabolic Systems;International Journal of Molecular Sciences;2023-03-11

3. Research Progress of Mineralocorticoid Receptor Antagonists on Diabetic Kidney Disease;Advances in Clinical Medicine;2023

4. Primary aldosteronism: A consequence of sugar and western Diet?;Medical Hypotheses;2022-03

5. Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3